M.J. Hallek: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications

M. Hallek, L. Wanders, S. Strohmeyer, B. Emmerich

Journal:

Annals of Hematology

Year:

1992

Language:

english

File:

PDF, 567 KB

english, 1992

52

Activity of serum thymidine kinase in non-Hodgkin lymphoma: Relationship to other prognostic factors

M. Hallek, B. Emmerich, S. Strohmeyer, R. Busch, A. Reichle, R. Senekowitsch

Journal:

Journal of Molecular Medicine

Year:

1988

Language:

english

File:

PDF, 733 KB

english, 1988

53

Effects of a bacterial extract on local immunity of the lung in patients with chronic bronchitis

B. Emmerich, H. P. Emslander, D. Milatovic, M. Hallek, K. Pachmann

Journal:

Year:

1990

Language:

english

File:

PDF, 304 KB

english, 1990

54

Hautgentherapie – Perspektiven des Gentransfers in Keratinozyten

Markus Braun-Falco, Michael Hallek

Journal:

Year:

1998

Language:

german

File:

PDF, 372 KB

german, 1998

55

Chronische lymphatische Leukämie Aktuelle Therapiekonzepte

M. Hallek, M. Bergmann, G. Brittinger, H. Döhner, P. Dreger, M. Herold, G. Hopfinger, U. Jäger, W. Knauf, C. Nerl, M. Rummel, B. Schmitt, C.M. Wendtner, B. Emmerich, für die Deutsche CLL-Studiengruppe

Journal:

Year:

2002

Language:

german

File:

PDF, 322 KB

german, 2002

56

Ältere Patienten in klinischen Studien

V. Goede, M. Hallek

Journal:

Year:

2007

Language:

german

File:

PDF, 359 KB

german, 2007

57

Altern und Innere Medizin

M. Hallek, W. Hiddemann

Journal:

Year:

2007

Language:

german

File:

PDF, 99 KB

german, 2007

58

Thrombotisch-thrombozytopenische Purpura

M. Hellmann, M. Hallek, I. Scharrer

Journal:

Year:

2010

Language:

german

File:

PDF, 662 KB

german, 2010

59

Multimodale Therapie des kolorektalen Karzinoms

U. Hacker, M. Hallek, S. Kubicka

Journal:

Year:

2010

Language:

german

File:

PDF, 434 KB

german, 2010

60

Onkologie und Palliativmedizin

J. Gärtner, J. Wolf, R. Voltz, M. Hallek

Journal:

Year:

2011

Language:

german

File:

PDF, 293 KB

german, 2011

61

Multimodale Therapie ausgewählter Tumorerkrankungen

M.P. Manns, M. Hallek

Journal:

Year:

2010

Language:

german

File:

PDF, 81 KB

german, 2010

62

Störungen der Thrombozytenfunktion

M. Hellmann, M. Hallek

Journal:

Year:

2010

Language:

german

File:

PDF, 76 KB

german, 2010

63

Was ist Palliativmedizin?

M. Hallek, H. Lehnert, R. Voltz

Journal:

Year:

2011

Language:

german

File:

PDF, 160 KB

german, 2011

64

Bronchialkarzinome

P. Zabel, M. Hallek

Journal:

Year:

2011

Language:

german

File:

PDF, 157 KB

german, 2011

65

Thyrosinkinaseinhibitoren in der Onkologie

T. Zander, M. Hallek

Journal:

Year:

2011

Language:

german

File:

PDF, 354 KB

german, 2011

66

Sonographie in der Inneren Medizin

M.P. Manns, S.M. Schellong, M. Hallek

Journal:

Year:

2012

Language:

german

File:

PDF, 165 KB

german, 2012

67

Grundlagen der Gentherapie Prinzipien und Stand der Entwicklung

M. Hallek, H. Buening, M. Ried, U. Hacker, Ch. Kurzeder, C.-M. Wendtner

Journal:

Year:

2001

Language:

german

File:

PDF, 255 KB

german, 2001

68

Recent advances in the biology and treatment of chronic lymphocytic leukemia and related diseases

B. Emmerich, M. Hallek

Journal:

Journal of Molecular Medicine

Year:

1999

Language:

english

File:

PDF, 10 KB

english, 1999

69

Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival

Gerold Meinhardt, Wendtner Clemens-M., M. Hallek

Journal:

Journal of Molecular Medicine

Year:

1999

Language:

english

File:

PDF, 178 KB

english, 1999

70

Methantheline improves the reactivation by HI 6 of human erythrocyte acetylcholinesterase inhibited by soman in vitro

M. Hallek, L. Szinicz

Journal:

Archives of Toxicology

Year:

1995

Language:

english

File:

PDF, 426 KB

english, 1995

71

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity

Ulrich T. Hacker, Ines Schildhauer, Margarita C. Barroso, David M. Kofler, Franz M. Gerner, Josef Mysliwietz, Hildegard Buening, Michael Hallek, Susan B. S. King

Journal:

Cancer Immunology, Immunotherapy

Year:

2006

Language:

english

File:

PDF, 380 KB

english, 2006

72

Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells

Michael Stanglmaier, Simone Reis, Michael Hallek

Journal:

Annals of Hematology

Year:

2004

Language:

english

File:

PDF, 433 KB

english, 2004

73

Src family tyrosine kinases phosphorylate Flt3 on juxtamembrane tyrosines and interfere with receptor maturation in a kinase-dependent manner

Olga Mitina, Markus Warmuth, Günter Krause, Michael Hallek, Axel Obermeier

Journal:

Annals of Hematology

Year:

2007

Language:

english

File:

PDF, 360 KB

english, 2007

74

Role of p21WAF1/CIP1as an attenuator of both proliferative and drug-induced apoptotic signals inBCR-ABL-transformed hematopoietic cells

Karin Forster, Axel Obermeier, Olga Mitina, Nicola Simon, Markus Warmuth, Günter Krause, Michael Hallek

Journal:

Annals of Hematology

Year:

2008

Language:

english

File:

PDF, 306 KB

english, 2008

75

Management of infections in patients with chronic lymphocytic leukemia treated with alemtuzumab

Thomas Elter, Janne J. Vehreschild, John Gribben, Oliver A. Cornely, Andreas Engert, Michael Hallek

Journal:

Annals of Hematology

Year:

2009

Language:

english

File:

PDF, 221 KB

english, 2009

76

Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab

Jens Marcus Chemnitz, Jens Uener, Michael Hallek, Christof Scheid

Journal:

Annals of Hematology

Year:

2010

Language:

english

File:

PDF, 102 KB

english, 2010

77

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia

Jens Marcus Chemnitz, Marie von Lilienfeld-Toal, Udo Holtick, Sebastian Theurich, Alexander Shimabukuro-Vornhagen, Anke Krause, Peter Brossart, Michael Hallek, Christof Scheid

Journal:

Annals of Hematology

Year:

2012

Language:

english

File:

PDF, 166 KB

english, 2012

78

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies

M. Warmuth, S. Danhauser-Riedl, M. Hallek

Journal:

Annals of Hematology

Year:

1999

Language:

english

File:

PDF, 161 KB

english, 1999

79

The activation of intracellular tyrosine kinases by interferon-alpha (IFNα) correlates with its antiproliferative activity in B-lymphoid cell lines, but not in B-cell chronic lymphocytic leukemia patients

N. von Bubnoff, S. Adler, S. Danhauser-Riedl, T. Kamp, C. Nerl, B. Emmerich, M. Hallek

Journal:

Annals of Hematology

Year:

2000

Language:

english

File:

PDF, 321 KB

english, 2000

80

Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia

O. Sezer, P. Schmid, M. Hallek, M. Schweigert, T. Beinert, C. Langelotz, H.-G. Mergenthaler, K. Possinger

Journal:

Annals of Hematology

Year:

1999

Language:

english

File:

PDF, 53 KB

english, 1999

81

Recombinant adeno-associated virus (rAAV) vector-mediated cotransduction of CD70 and CD80 into human malignant melanoma cells results in an additive T-cell response

M. Braun-Falco, Michael Hallek

Journal:

Archives of Dermatological Research

Year:

2001

Language:

english

File:

PDF, 84 KB

english, 2001

82

Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy

Bernd Koppold, Georg Sauer, Hildegard Buening, Michael Hallek, Rolf Kreienberg, Helmut Deissler, Christian Kurzeder

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2006

Language:

english

File:

PDF, 304 KB

english, 2006

83

A cost calculation model for specialist palliative care for patients with non-small cell lung cancer in a tertiary centre

Christoph Ostgathe, Ronald Walshe, Jürgen Wolf, Michael Hallek, Raymond Voltz

Journal:

Supportive Care in Cancer

Year:

2008

Language:

english

File:

PDF, 108 KB

english, 2008

84

Determinants and implications of cancer patients’ psychosocial needs

N. Ernstmann, M. Neumann, O. Ommen, M. Galushko, M. Wirtz, R. Voltz, M. Hallek, H. Pfaff

Journal:

Supportive Care in Cancer

Year:

2009

Language:

english

File:

PDF, 148 KB

english, 2009

85

Standardizing integration of palliative care into comprehensive cancer therapy—a disease specific approach

Jan Gaertner, Juergen Wolf, Michael Hallek, Jan-Peter Glossmann, Raymond Voltz

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 172 KB

english, 2011

86

Recommending early integration of palliative care — does it work?

Jan Gaertner, Juergen Wolf, Sebastian Frechen, Ursula Klein, Dennis Scheicht, Martin Hellmich, Karin Toepelt, Jan-Peter Glossmann, Christoph Ostgathe, Michael Hallek, Raymond Voltz

Journal:

Supportive Care in Cancer

Year:

2012

Language:

english

File:

PDF, 143 KB

english, 2012

87

Neue Therapiestrategien bei chronischer lympathischer Leukämie

G. Fingerle-Rowson, M. Hallek

Journal:

Year:

2003

Language:

german

File:

PDF, 274 KB

german, 2003

88

Chronische lymphatische Leukämie

B. Eichhorst, M. Hallek

Journal:

Year:

2006

Language:

german

File:

PDF, 828 KB

german, 2006

89

Molekular- und zellbiologische Strategien zur Entwicklung einer adjuvanten Lymphomtherapie

M. Hallek, R. Buhmann, A. Doenecke, R. Magerstaedt, A. Nolte, C. M. Wendtner, B. Emmerich

Journal:

Year:

1997

Language:

german

File:

PDF, 301 KB

german, 1997

90

An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX)

Norma Jung, Matthias Hellmann, Reimund Hoheisel, Clara Lehmann, Ingo Haase, Andreas Perniok, Michael Hallek, Andrea Rubbert

Journal:

Clinical Rheumatology

Year:

2010

Language:

english

File:

PDF, 114 KB

english, 2010

91

Chronische lymphatische Leukämie

K. Fischer, M. Hallek

Journal:

Best Practice Onkologie

Year:

2008

Language:

german

File:

PDF, 519 KB

german, 2008

92

Eradication of minimal residual disease in chronic lymphocytic leukemia

Carmen Diana Schweighofer, Michael Hallek, Clemens-Martin Wendtner

Journal:

Current Hematologic Malignancy Reports

Year:

2008

Language:

english

File:

PDF, 168 KB

english, 2008

93

Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma?

Thomas Elter, Martina Stipanov, Eva Heuser, Michael von Bergwelt-Baildon, Wilhelm Bloch, Michael Hallek, Freerk Baumann

Journal:

International Journal of Hematology

Year:

2009

Language:

english

File:

PDF, 193 KB

english, 2009

94

Recent developments and future perspectives in the systemic treatment of metastatic colorectal cancer

O. Coutelle, M. Hallek, U. T. Hacker

Journal:

memo - Magazine of European Medical Oncology

Year:

2011

Language:

english

File:

PDF, 201 KB

english, 2011

95

Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy

Barbara F. Eichhorst, Raymonde Busch, Carmen Schweighofer, Clemens M. Wendtner, Berthold Emmerich, Michael Hallek, the German CLL Study Group (GCLLSG)

Journal:

British Journal of Haematology

Year:

2007

Language:

english

File:

PDF, 488 KB

english, 2007

96

Consolidation with alemtuzumab improves progression-free survival in patients with chronic lymphocytic leukaemia (CLL) in first remission – long-term follow-up of a randomized phase III trial of the German CLL Study Group (GCLLSG)

Carmen D. Schweighofer, Matthias Ritgen, Barbara F. Eichhorst, Raymonde Busch, Wolfgang Abenhardt, Michael Kneba, Michael Hallek, Clemens-Martin Wendtner

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 112 KB

english, 2009

97

Rediscovering alemtuzumab: current and emerging therapeutic roles

John G. Gribben, Michael Hallek

Journal:

British Journal of Haematology

Year:

2009

Language:

english

File:

PDF, 170 KB

english, 2009

98

Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells

Michaela Patz, Polina Isaeva, Nche Forcob, Bianka Müller, Lukas P. Frenzel, Clemens-Martin Wendtner, Christian Klein, Pablo Umana, Michael Hallek, Günter Krause

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 297 KB

english, 2011

99

Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis

Lukas P. Frenzel, Michaela Patz, Christian P. Pallasch, Reinhild Brinker, Julia Claasen, Alexandra Schulz, Michael Hallek, Hamid Kashkar, Clemens-Martin Wendtner

Journal:

British Journal of Haematology

Year:

2011

Language:

english

File:

PDF, 333 KB

english, 2011

100

Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients

Maria J. G. T. Rüping, Carsten Müller, Jörg J. Vehreschild, Angelika Böhme, Sabine Mousset, Urs Harnischmacher, Peter Frommolt, Gernot Wassmer, Ivonne Drzisga, Michael Hallek, Oliver A. Cornely

Journal:

Year:

2011

Language:

english

File:

PDF, 95 KB

english, 2011

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски